{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:12:18Z","timestamp":1791245538229,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004897","name":"European Organisation for Research and Treatment of Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.radonc.2020.02.013","type":"journal-article","created":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T12:05:34Z","timestamp":1583582734000},"page":"143-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Generalizability assessment of head and neck cancer NTCP models based on the TRIPOD criteria"],"prefix":"10.1016","volume":"146","author":[{"given":"Marjan","family":"Sharabiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Clementel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaus","family":"Andratschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coen","family":"Hurkmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2020.02.013_b0005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.radonc.2015.07.041","article-title":"CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines","volume":"117","author":"Brouwer","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0010","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.radonc.2003.09.011","article-title":"CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines","volume":"69","author":"Gr\u00e9goire","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0015","article-title":"Guidelines for delineation of lymphatic clinical target volumes for high conformal radiotherapy","volume":"6","author":"Vorwerk","year":"2011","journal-title":"Head Neck Region"},{"key":"10.1016\/j.radonc.2020.02.013_b0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.radonc.2008.12.017","article-title":"A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer","volume":"90","author":"Langendijk","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0025","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","article-title":"Assessing the performance of prediction models: a framework for traditional and novel measures","volume":"21","author":"Steyerberg","year":"2010","journal-title":"Epidemiology"},{"key":"10.1016\/j.radonc.2020.02.013_b0030","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.eururo.2014.11.025","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement","volume":"67","author":"Collins","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.radonc.2020.02.013_b0035","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ijrobp.2017.09.041","article-title":"Systematic review of normal tissue complication models relevant to standard fractionation radiation therapy of the head and neck region published after the QUANTEC reports","volume":"100","author":"Brodin","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.02.013_b0040","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.radonc.2016.08.022","article-title":"Toward a model-based patient selection strategy for proton therapy: External validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort","volume":"121","author":"Blanchard","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0045","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1080\/0284186X.2019.1654129","article-title":"NTCP model validation method for DAHANCA patient selection of protons versus photons in head and neck cancer radiotherapy","volume":"58","author":"Hansen","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0050","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.oraloncology.2012.07.004","article-title":"Scintigraphic assessment of salivary function after intensity-modulated radiotherapy for head and neck cancer: Correlations with parotid dose and quality of life","volume":"49","author":"Chen","year":"2013","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0055","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2407-12-567","article-title":"Normal tissue complication probability model parameter estimation for xerostomia in head and neck cancer patients based on scintigraphy and quality of life assessments","volume":"12","author":"Lee","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2020.02.013_b0060","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.radonc.2011.05.010","article-title":"Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: the role of dosimetric and clinical factors","volume":"105","author":"Beetz","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0065","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.radonc.2011.11.006","article-title":"External validation of three dimensional conformal radiotherapy based NTCP models for patient-rated xerostomia and sticky saliva among patients treated with intensity modulated radiotherapy","volume":"105","author":"Beetz","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.radonc.2012.03.004","article-title":"NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors","volume":"105","author":"Beetz","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0075","article-title":"Using multivariate regression model with least absolute shrinkage and selection operator (LASSO) to predict the incidence of xerostomia after intensity-modulated radiotherapy for head and neck cancer","volume":"9","author":"Lee","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.radonc.2020.02.013_b0080","article-title":"LASSO NTCP predictors for the incidence of xerostomia in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma","volume":"4","author":"Lee","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.radonc.2020.02.013_b0085","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ijrobp.2011.04.020","article-title":"Treatment planning constraints to avoid xerostomia in head-and-neck radiotherapy: an independent test of QUANTEC criteria using a prospectively collected dataset","volume":"82","author":"Moiseenko","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.02.013_b0090","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.ijrobp.2009.07.1685","article-title":"A comparison of dose-response models for the parotid gland in a large group of head-and-neck cancer patients","volume":"76","author":"Houweling","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.02.013_b0095","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/0284186X.2017.1324209","article-title":"Parotid gland mean dose as a xerostomia predictor in low-dose domains","volume":"56","author":"Gabry\u015b","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0100","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.ijrobp.2008.11.020","article-title":"Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy","volume":"73","author":"Marzi","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.02.013_b0105","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.radonc.2013.03.009","article-title":"Dose\u2013response analysis of parotid gland function: What is the best measure of xerostomia?","volume":"106","author":"Miah","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0110","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0360-3016(01)01717-5","article-title":"Qantitative dose-volume response analysis of changes in parotid gland function after radiotheraphy in the head-and-neck region","volume":"51","author":"Roesink","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.02.013_b0115","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.ijrobp.2008.02.059","article-title":"Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy","volume":"72","author":"Dijkema","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.02.013_b0120","article-title":"Patient- and therapy-related factors associated with the incidence of xerostomia in nasopharyngeal carcinoma patients receiving parotid-sparing helical tomotherapy","volume":"5","author":"Lee","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.radonc.2020.02.013_b0125","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.radonc.2017.06.020","article-title":"Dose\u2013volume toxicity modeling for de-intensified chemo-radiation therapy for HPV-positive oropharynx cancer","volume":"124","author":"Mavroidis","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0130","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijrobp.2009.07.1708","article-title":"Parotid gland function after radiotherapy: the combined Michigan and Utrecht experience","volume":"78","author":"Dijkema","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.02.013_b0135","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.radonc.2011.08.009","article-title":"Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study","volume":"105","author":"Christianen","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0140","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.radonc.2015.11.009","article-title":"Swallowing sparing intensity modulated radiotherapy (SW-IMRT) in head and neck cancer: clinical validation according to the model-based approach","volume":"118","author":"Christianen","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0145","first-page":"27","article-title":"Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapy","volume":"8","author":"Dean","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0150","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.radonc.2011.12.027","article-title":"Dose\u2013response analysis of acute oral mucositis and pharyngeal dysphagia in patients receiving induction chemotherapy followed by concomitant chemo-IMRT for head and neck cancer","volume":"103","author":"Bhide","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0155","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00066-017-1206-x","article-title":"Strahleninduzierte akute Dysphagie: Prospektive Beobachtungsstudie an 42 Kopf-Hals-Malignompatienten","volume":"193","author":"Alterio","year":"2017","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2020.02.013_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/CCI.17.00070","article-title":"Modeling dose response for late dysphagia in patients with head and neck cancer in the modern era of definitive chemoradiation","volume":"1","author":"Tsai","year":"2017","journal-title":"JCO Clin Cancer Informatics"},{"key":"10.1016\/j.radonc.2020.02.013_b0165","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.radonc.2014.09.013","article-title":"Development of a multivariable normal tissue complication probability (NTCP) model for tube feeding dependence after curative radiotherapy\/chemo-radiotherapy in head and neck cancer","volume":"113","author":"Wopken","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0170","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.radonc.2018.09.013","article-title":"External validation of a multifactorial normal tissue complication probability model for tube feeding dependence at 6\u202fmonths after definitive radiotherapy for head and neck cancer","volume":"129","author":"Kanayama","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094879","article-title":"Development and validation of a prediction model for tube feeding dependence after curative (chemo-) radiation in head and neck cancer","volume":"9","author":"Wopken","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.radonc.2020.02.013_b0180","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2016.05.015","article-title":"Normal tissue complication probability (NTCP) modelling using spatial dose metrics and machine learning methods for severe acute oral mucositis resulting from head and neck radiotherapy","volume":"120","author":"Dean","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0185","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.clon.2016.12.001","article-title":"Normal Tissue Complication Probability (NTCP) modelling of severe acute mucositis using a novel oral mucosal surface organ at risk","volume":"29","author":"Dean","year":"2017","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0190","doi-asserted-by":"crossref","first-page":"e697","DOI":"10.1016\/j.ijrobp.2012.02.004","article-title":"A new model for predicting acute mucosal toxicity in head-and-neck cancer patients undergoing radiotherapy with altered schedules","volume":"83","author":"Strigari","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.02.013_b0195","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-015-0501-x","article-title":"Normal tissue complication probability modeling for cochlea constraints to avoid causing tinnitus after head-and-neck intensity-modulated radiation therapy","volume":"10","author":"Lee","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0200","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1080\/09553002.2017.1385872","article-title":"Normal tissue complication probability modeling of radiation-induced sensorineural hearing loss after head-and-neck radiation therapy","volume":"93","author":"Cheraghi","year":"2017","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.radonc.2020.02.013_b0205","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20140413","article-title":"Use of gEUD for predicting ear and pituitary gland damage following proton and photon radiation therapy","volume":"88","author":"De Marzi","year":"2015","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2020.02.013_b0210","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejmp.2019.04.003","article-title":"Dose-response relationship and normal-tissue complication probability of conductive hearing loss in patients undergoing head-and-neck or cranial radiotherapy: a prospective study including 70 ears","volume":"61","author":"Mosleh-Shirazi","year":"2019","journal-title":"Physica Med"},{"key":"10.1016\/j.radonc.2020.02.013_b0215","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ijrobp.2012.03.034","article-title":"Normal tissue complication probability modeling of radiation-induced hypothyroidism after head-and-neck radiation therapy","volume":"85","author":"Bakhshandeh","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.02.013_b0220","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1016\/j.ijrobp.2012.05.020","article-title":"A prospective cohort study on radiation-induced hypothyroidism: development of an NTCP model","volume":"84","author":"Boomsma","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.02.013_b0225","doi-asserted-by":"crossref","DOI":"10.1186\/1748-717X-7-224","article-title":"Development of multivariate NTCP models for radiation-induced hypothyroidism: a comparative analysis","volume":"7","author":"Cella","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0230","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.radonc.2013.06.029","article-title":"Hypothyroidism after primary radiotherapy for head and neck squamous cell carcinoma: normal tissue complication probability modeling with latent time correction","volume":"109","author":"R\u00f8njom","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0235","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3109\/0284186X.2015.1064160","article-title":"External validation of a normal tissue complication probability model for radiation-induced hypothyroidism in an independent cohort","volume":"54","author":"R\u00f8njom","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0240","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-4348-z","article-title":"Development of a normal tissue complication probability (NTCP) model for radiation-induced hypothyroidism in nasopharyngeal carcinoma patients","volume":"18","author":"Luo","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2020.02.013_b0245","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1016\/j.ijrobp.2012.03.027","article-title":"Acute esophagus toxicity in lung cancer patients after intensity modulated radiation therapy and concurrent chemotherapy","volume":"84","author":"Kwint","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.02.013_b0250","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.radonc.2015.08.010","article-title":"Multivariable normal-tissue complication modeling of acute esophageal toxicity in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy","volume":"117","author":"Wijsman","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0255","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.radonc.2018.07.021","article-title":"External validation of an NTCP model for acute esophageal toxicity in locally advanced NSCLC patients treated with intensity-modulated (chemo-)radiotherapy","volume":"129","author":"Dankers","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0260","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.ijrobp.2011.02.052","article-title":"Modeling the risk of radiation-induced acute esophagitis for combined Washington University and RTOG trial 93\u201311 lung cancer patients","volume":"82","author":"Huang","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.02.013_b0265","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.radonc.2010.09.025","article-title":"Analysis of acute radiation-induced esophagitis in non-small-cell lung cancer patients using the Lyman NTCP model","volume":"97","author":"Zhu","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0270","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.radonc.2005.10.001","article-title":"Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer","volume":"77","author":"Chapet","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0275","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2005.03.021","article-title":"Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy","volume":"75","author":"Belderbos","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0280","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-015-0429-1","article-title":"Normal tissue complication models for clinically relevant acute esophagitis (\u2265 grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid)","volume":"10","author":"Zehentmayr","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0285","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1080\/02841860310012833","article-title":"Determination and clinical verification of dose-response parameters for esophageal stricture from head and neck radiotherapy","volume":"42","author":"Mavroidis","year":"2003","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0290","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.radonc.2013.08.017","article-title":"Severe late esophagus toxicity in NSCLC patients treated with IMRT and concurrent chemotherapy","volume":"108","author":"Chen","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.02.013_b0295","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.ijrobp.2010.12.067","article-title":"Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates","volume":"81","author":"Eisbruch","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814020300761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814020300761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:10:30Z","timestamp":1759122630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814020300761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":59,"alternative-id":["S0167814020300761"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2020.02.013","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generalizability assessment of head and neck cancer NTCP models based on the TRIPOD criteria","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2020.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}